Shipping with this method takes 3-5 days
Juluca® Tablets for HIV-1 Maintenance
Stock up and Save - Get 20% off when you buy 3 or more of any one product. Use code SAVE20 at checkout.
Coupon code cannot be combined with other offers. Sale applies to all products originating from Canada. Maximum allowable quantity equal to a 90 day supply per single order.
$1,835.99
Secure Encrypted Payments
Juluca is a prescription HIV-1 maintenance treatment for adults who are already undetectable. It helps you stay on a simple, once-daily regimen and shows how to switch safely. This page explains clinical basics, usage, and access with US delivery from Canada, including options if you pay Juluca without insurance.
What Juluca Is and How It Works
Juluca® combines dolutegravir, an integrase inhibitor, and rilpivirine, a non-nucleoside reverse transcriptase inhibitor. Together, they block HIV replication at two different steps. It is used as a replacement regimen for people whose HIV-1 is already virologically suppressed on a stable therapy, with no history of treatment failure and no known or suspected resistance to either component.
YouDrugstore is a licensed Canadian pharmacy in Manitoba. Pharmacists review prescriptions before dispensing.
This medicine must be taken with a meal, as food improves rilpivirine absorption. It is not suitable for starting therapy in untreated patients. Your clinician may order periodic labs to confirm that suppression is maintained.
Who It’s For
This treatment is for adults with HIV-1 who are undetectable on their current regimen. It may be considered when you want to reduce pill count while maintaining suppression. People with known resistance to integrase inhibitors or NNRTIs, or with a history of virologic failure, should not use this combination.
Those with significant liver disease, a history of depression or other mood disorders, or who take medicines that strongly affect CYP3A should discuss risks and alternatives. For pregnancy or breastfeeding, decisions are individualized; review the official label and speak with a healthcare professional. For broader condition support, see our HIV Care category.
Dosage and Usage
The usual dose is one tablet once daily with a meal. A meal is required; a protein drink alone does not replace food. Swallow the tablet whole with water. If you take antacids, mineral supplements, or H2 blockers, follow spacing rules noted below to avoid lowering absorption.
Do not change your regimen on your own. When uncertain about timing with other medicines, refer to the official prescribing information or ask a clinician. This therapy is not indicated for children or for initial HIV treatment.
Strengths and Forms
The fixed-dose tablet contains dolutegravir 50 mg and rilpivirine 25 mg. Bottles commonly contain 30 tablets; availability may vary by market and stock.
Missed Dose and Timing
If you miss a dose, take it as soon as you remember with a meal. If it is almost time for your next dose, skip the missed dose and resume your regular schedule. If you vomit within about 4 hours after taking it, the label advises taking another tablet with food; if more time has passed, usually wait until the next dose. When timing questions are unclear, check the official label.
Storage and Travel Basics
Store at room temperature in the original bottle with the desiccant. Keep the cap tightly closed to protect from moisture, and keep out of reach of children and pets. Do not store in a bathroom. For travel, carry it in your hand luggage, bring your prescription label, and keep dosing aligned with meals as you cross time zones. If your trip involves security checks, keep the pharmacy label attached to avoid delays.
Benefits
This two-drug regimen reduces daily pill burden while maintaining a complete antiretroviral therapy. Once-daily dosing with food simplifies routines. The treatment avoids tenofovir and abacavir, which may be helpful for some patients with kidney or cardiovascular considerations. Many people report fewer regimen components to manage, though individual experiences can vary.
Side Effects and Safety
- Common: headache, nausea, diarrhea
- Other reported: insomnia, dizziness, abnormal dreams
- Skin: rash, which is usually mild
Serious effects are uncommon but can include severe skin reactions, liver problems, mood changes, or depression. Rilpivirine has been associated with QT prolongation at higher exposures; use caution with other QT-prolonging drugs. Immune reconstitution syndrome may occur in some patients as the immune system recovers. Seek urgent care for symptoms of severe rash, yellowing of skin or eyes, or worsening mood.
Drug Interactions and Cautions
Avoid proton pump inhibitors (such as omeprazole), as rilpivirine requires stomach acidity. H2 blockers should be spaced (take them at least 12 hours before or 4 hours after your dose). Antacids or products with aluminum, magnesium, calcium, or iron can bind dolutegravir; take this medicine at least 2 hours before or 6 hours after them, or take mineral supplements with the dose if taken with a meal.
Avoid strong CYP3A inducers such as rifampin, carbamazepine, phenobarbital, phenytoin, and St. John’s wort. Multiple-dose systemic dexamethasone is also not recommended. For a broader overview, see our Drug Interactions Guide. Review all medicines, including over-the-counter and herbal products, with your prescriber.
What to Expect Over Time
If taken correctly with food, most patients who switch from a stable, suppressive regimen remain undetectable on follow-up testing. Mild gastrointestinal or sleep-related effects may occur early and often lessen. Keep scheduled lab monitoring and report new symptoms promptly. Adherence matters; set reminders tied to meals and bring enough tablets for travel. For additional context on HIV care choices, you may find our overview on Delstrigo Medication and the awareness feature on HIV Testing Day helpful.
Compare With Alternatives
Two other complete options many clinicians consider are once-daily combinations. Dovato® pairs dolutegravir with lamivudine and is a two-drug complete regimen for treatment-naive adults without certain baseline resistance or hepatitis B coinfection. Odefsey® combines emtricitabine, rilpivirine, and tenofovir alafenamide; it is food-dependent and is commonly used for suppressed patients or select initial therapy situations. Your prescriber will match therapy to your history, lab results, and drug interaction profile.
Pricing and Access
We list current Dolutegravir rilpivirine tablets price transparently, with Canadian pricing and US delivery from Canada. Check live availability on this page and review generic status when applicable. For potential savings, explore our Promotions page. Checkout is encrypted.
If you want to Order dolutegravir rilpivirine online, add it to your cart and upload your prescription. Our team can coordinate transfers if your prescriber sends a script directly. You can also browse related options within Antivirals for context before you decide.
Availability and Substitutions
Supply varies by distributor and lot timing. If an item is temporarily unavailable, your prescriber may recommend an alternative in the same class or a complete regimen that fits your history. You can still discuss whether to Order Juluca tablets once stock returns or consider another maintenance option guided by your clinician.
Patient Suitability and Cost-Saving Tips
Good candidates are adults who are virologically suppressed, have no resistance to the components, and can reliably take a daily dose with a meal. Those with significant liver disease, certain psychiatric conditions, or complex polypharmacy may need closer oversight. It is not designed for children or for starting HIV therapy.
To manage costs, consider 60- or 90-day fills if prescribed, and set refill reminders before you run low. Compare Canadian pricing against local pharmacy quotes. If you prefer smaller quantities, you may still Buy Juluca 30 tablets to align with a monthly schedule. Keep all documentation ready for refills to avoid delays.
Questions to Ask Your Clinician
- Is my resistance and treatment history suitable for this two-drug regimen?
- How should I time doses with meals during travel or shift work?
- Do any of my current medicines or supplements interact with this treatment?
- Which labs will you monitor and how often?
- What signs of liver or mood problems should prompt a call?
- Could an alternative regimen fit better with my comorbidities?
Authoritative Sources
Ready to proceed? Add to cart to Buy dolutegravir rilpivirine 50/25 mg with US delivery from Canada, and choose prompt shipping; temperature-controlled handling when required. This content is for general information and does not replace your prescriber’s advice.
Express Shipping - from $25.00
Prices:
- Dry-Packed Products $25.00
- Cold-Packed Products $35.00
Shipping Countries:
- United States (all contiguous states**)
- Worldwide (excludes some countries***)
Standard Shipping - $15.00
Shipping with this method takes 5-10 days
Prices:
- Dry-Packed Products $15.00
- Not available for Cold-Packed products
Shipping Countries:
- United States (all contiguous states**)
- Worldwide (excludes some countries***)
Do I need to take this with food every time?
Yes. This therapy relies on food to ensure rilpivirine is absorbed adequately. Take the dose with a meal, not just a nutritional drink. Consistency helps maintain drug levels and reduces the chance of breakthrough. If your schedule is irregular, pair your dose with the day’s largest reliable meal. Ask your healthcare professional how to handle dosing during fasting or shift work. Review the official label for detailed guidance on meal types.
What if I vomit after taking a dose?
If you vomit within about four hours of taking the tablet, the label advises taking another tablet with food. If vomiting occurs later, wait until the next scheduled dose. Hydrate as needed, and monitor how you feel. If vomiting persists or you’re unsure about timing, contact your prescriber or pharmacist for individualized advice based on your regimen and other medicines.
Can I use antacids or acid reducers with this regimen?
Avoid proton pump inhibitors. If you need an H2 blocker like famotidine, take it at least 12 hours before or 4 hours after your dose. For antacids or mineral supplements containing aluminum, magnesium, calcium, or iron, separate by at least 2 hours before or 6 hours after. Meals help with mineral interactions, but spacing is still important. For more detail, bring a list of products to your pharmacist.
Is this therapy suitable during pregnancy or breastfeeding?
Pregnancy decisions are individualized. Some data exist for the components, but recommendations vary by trimester and patient history. If you are pregnant, planning pregnancy, or breastfeeding, discuss risks and benefits with your prescriber. They will weigh your viral suppression status, safety profiles, and alternatives. Do not start, stop, or switch antiretrovirals without medical guidance, and review the official label for the most current information.
What monitoring will I need after switching?
Your clinician will check viral load and CD4 regularly, especially after the switch. They may also monitor liver enzymes and assess mood or sleep changes. Follow-up timing varies by clinic practice and prior history. Keep all appointments and bring an updated medication list. If lab access is difficult, ask about local testing options or timing during travel to maintain consistent care.
Are there common side effects I should expect?
The most reported effects include headache, nausea, and diarrhea. Some people notice insomnia or vivid dreams, especially early on. These are often mild and may lessen with time. Rare but serious problems include severe skin reactions, liver issues, or mood changes. Contact a healthcare professional urgently for rash with fever, yellowing of skin or eyes, or worsening depression. Report any effect that concerns you.
Who should avoid this medicine?
People with known or suspected resistance to integrase inhibitors or non-nucleoside reverse transcriptase inhibitors should not use this combination. It is not intended for initial HIV treatment or for children. Avoid with strong CYP3A inducers and proton pump inhibitors. Individuals with significant liver disease, prolonged QT risks, or certain psychiatric histories should discuss the balance of benefits and risks with a clinician before switching.
